John L. Lamattina, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 9,670 shares at $161.86 ($1.6M) on 2021-11-16, disclosed to the SEC on 2021-11-17.
Seasonal sale ($1.6M) by Director — this insider has traded LGND in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $161.86 | 4,835 | $783K | 50.0% |
| 2 | $161.86 | 4,835 | $783K | 50.0% |
| Total | $161.86 avg | 9,670 | $1.6M | 100% |
| Filing → |
| LGND | SELL | 2025-11-12 | $1.7M | — | Filing → |
| LGND | SELL | 2024-12-02 | $595K | — | Filing → |
| IMNM | BUY | 2021-05-26 | $196K | — | Filing → |